A HER2 Antibody Drug Conjugate Controls Growth of Breast Cancer Brain Metastases in Hematogenous Xenograft Models, with Heterogeneous Blood-Tumor Barrier Penetration Unlinked to a Passive Marker
about
A HER2 Antibody Drug Conjugate Controls Growth of Breast Cancer Brain Metastases in Hematogenous Xenograft Models, with Heterogeneous Blood-Tumor Barrier Penetration Unlinked to a Passive Marker
description
scientific article published on 09 May 2020
@en
name
A HER2 Antibody Drug Conjugate ...... n Unlinked to a Passive Marker
@en
type
label
A HER2 Antibody Drug Conjugate ...... n Unlinked to a Passive Marker
@en
prefLabel
A HER2 Antibody Drug Conjugate ...... n Unlinked to a Passive Marker
@en
P2093
P356
P1433
P1476
A HER2 Antibody Drug Conjugate ...... n Unlinked to a Passive Marker
@en
P2093
Alexandra S Zimmer
Brunilde Gril
Christina Robinson
Debbie Wei
Imran Khan
Patricia S Steeg
Simone Difilippantonio
P356
10.1093/NEUONC/NOAA118
P577
2020-05-09T00:00:00Z